Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20012 | 416 | 39.7 | 85% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 370 | 16580 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NO ASPIRIN | Author keyword | 24 | 82% | 3% | 14 |
| 2 | NITROASPIRIN | Author keyword | 24 | 91% | 2% | 10 |
| 3 | NCX 4016 | Author keyword | 15 | 68% | 3% | 13 |
| 4 | PHOSPHO SULINDAC | Author keyword | 15 | 88% | 2% | 7 |
| 5 | NO NSAIDS | Author keyword | 13 | 61% | 3% | 14 |
| 6 | NITROPARACETAMOL | Author keyword | 11 | 100% | 1% | 6 |
| 7 | NITROFLURBIPROFEN | Author keyword | 8 | 75% | 1% | 6 |
| 8 | NO RELEASING ASPIRIN | Author keyword | 6 | 71% | 1% | 5 |
| 9 | NITRIC OXIDE DONATING ASPIRIN | Author keyword | 6 | 100% | 1% | 4 |
| 10 | NO NSAID | Author keyword | 4 | 50% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NO ASPIRIN | 24 | 82% | 3% | 14 | Search NO+ASPIRIN | Search NO+ASPIRIN |
| 2 | NITROASPIRIN | 24 | 91% | 2% | 10 | Search NITROASPIRIN | Search NITROASPIRIN |
| 3 | NCX 4016 | 15 | 68% | 3% | 13 | Search NCX+4016 | Search NCX+4016 |
| 4 | PHOSPHO SULINDAC | 15 | 88% | 2% | 7 | Search PHOSPHO+SULINDAC | Search PHOSPHO+SULINDAC |
| 5 | NO NSAIDS | 13 | 61% | 3% | 14 | Search NO+NSAIDS | Search NO+NSAIDS |
| 6 | NITROPARACETAMOL | 11 | 100% | 1% | 6 | Search NITROPARACETAMOL | Search NITROPARACETAMOL |
| 7 | NITROFLURBIPROFEN | 8 | 75% | 1% | 6 | Search NITROFLURBIPROFEN | Search NITROFLURBIPROFEN |
| 8 | NO RELEASING ASPIRIN | 6 | 71% | 1% | 5 | Search NO+RELEASING+ASPIRIN | Search NO+RELEASING+ASPIRIN |
| 9 | NITRIC OXIDE DONATING ASPIRIN | 6 | 100% | 1% | 4 | Search NITRIC+OXIDE+DONATING+ASPIRIN | Search NITRIC+OXIDE+DONATING+ASPIRIN |
| 10 | NO NSAID | 4 | 50% | 1% | 6 | Search NO+NSAID | Search NO+NSAID |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ULCEROGENIC PROPERTIES | 20 | 49% | 7% | 30 |
| 2 | OXIDE RELEASING ASPIRIN | 19 | 50% | 6% | 27 |
| 3 | NITROASPIRIN NCX 4016 | 18 | 89% | 2% | 8 |
| 4 | TRADITIONAL NSAIDS | 13 | 69% | 3% | 11 |
| 5 | NCX 4016 | 11 | 67% | 2% | 10 |
| 6 | OXIDE DONATING ASPIRIN | 10 | 52% | 3% | 14 |
| 7 | SULINDAC OXT 328 | 9 | 83% | 1% | 5 |
| 8 | NITROPARACETAMOL | 8 | 75% | 1% | 6 |
| 9 | DONATING ASPIRIN | 8 | 52% | 3% | 11 |
| 10 | MDC 917 | 8 | 100% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The Evolving Role of Nonsteroidal Anti-Inflammatory Drugs in Colon Cancer Prevention: A Cause for Optimism | 2015 | 1 | 77 | 21% |
| NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action | 2008 | 29 | 50 | 68% |
| Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis | 2009 | 29 | 52 | 35% |
| Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs | 2002 | 117 | 112 | 46% |
| Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer | 2008 | 43 | 35 | 31% |
| The therapeutic potential of NO-NSAIDs | 2003 | 98 | 79 | 37% |
| Therapeutic potential of nitrate esters of commonly used drugs | 2005 | 18 | 85 | 75% |
| Nitric-oxide-donating NSAIDs as agents for cancer prevention | 2004 | 75 | 34 | 32% |
| Cyclo-oxygenase (COX) inhibiting nitric oxide donating (CINODs) drugs: A review of their current status | 2007 | 21 | 25 | 44% |
| Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders | 2006 | 22 | 82 | 51% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SARAH C UPHAM GASTROENTEROL | 4 | 75% | 0.7% | 3 |
| 2 | BRADER CANC | 3 | 100% | 0.7% | 3 |
| 3 | CLIN GASTROENTEROL EPATOL | 3 | 23% | 2.9% | 12 |
| 4 | EXPT MED ENVIRONM BIOTECHNOL | 1 | 100% | 0.5% | 2 |
| 5 | MESSENGERS SIGNALLING GRP | 1 | 25% | 1.0% | 4 |
| 6 | PRECLIN EXPT | 1 | 25% | 0.7% | 3 |
| 7 | CATEDRA GASTROENTEROL ENZIMOL CLIN | 1 | 33% | 0.5% | 2 |
| 8 | PROGRAMA ESTUDIOS PANCREAT | 1 | 33% | 0.5% | 2 |
| 9 | CARDIOL I MONZINO | 1 | 50% | 0.2% | 1 |
| 10 | DIPARTIMENTO NEUROSCI PSICOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000116065 | LAFUTIDINE//CAPSAICIN SENSITIVE SENSORY NEURON//GASTRIC MUCIN BIOSYNTHESIS |
| 2 | 0.0000112326 | DIAZENIUMDIOLATE//JS K//DIAZENIUMDIOLATES |
| 3 | 0.0000094050 | COLLAGENOUS PROTEIN BIOSYNTHESIS//NOS3//IMMUNOL IMMUNOTHER IE CANC |
| 4 | 0.0000093908 | DIFFUSION CELL EXPERIMENTS//TRANSFORMED POTTS GUY EQUATION//ROBERTS SLOAN EQUATION |
| 5 | 0.0000082536 | PROSTAGLANDIN H SYNTHASE//IMRECOXIB//AB HANCOCK JR MEM CANC |
| 6 | 0.0000080548 | DIAPHRAGM DISEASE//SMALL INTESTINAL INJURY//SMALL INTESTINAL DAMAGE |
| 7 | 0.0000077765 | CELL PHYSIOL MOL IMAGE//ANESTHET TOXICOL//CELL BIOL MOL IMAGE |
| 8 | 0.0000068993 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
| 9 | 0.0000068089 | CYCLOOXYGENASE 2//COX 2//CELECOXIB |
| 10 | 0.0000065761 | NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY |